Intrinsic Value of S&P & Nasdaq Contact Us

Precigen, Inc. PGEN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+51.5%

Stock Statistics — PGEN

Precigen, Inc. (PGEN) has a market capitalization of $1.19B and trades at $3.96. The 52-week range is 1.11-5.47.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.8, Earnings Per Share (EPS) of $-1.41, annual revenue of $9.68M.

The stock has a beta of 1.12, operates in the Healthcare sector.

Trading Data
Current Price$3.96
52-Week Range1.11-5.47
Volume4.18M
Avg Volume (30D)5.6M
Market Cap$1.19B
Beta (1Y)1.12
Company
IPO Date2013-08-08
Employees143
CEOHelen Sabzevari
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS74017N1054
CUSIP74017N105
Income (Latest Year)
Revenue$9.68M
Gross Profit$3.59M
EBITDA$-103.4M
Operating Income$-106.6M
Net Income$-250.64M
EPS$-1.41
EPS Diluted$-1.41
Shares Outstanding$304.71M
Balance Sheet (Latest Year)
Total Assets$156.62M
Current Assets$115.24M
Cash & ST Investments$97.86M
Total Liabilities$135.71M
Total Debt$5.12M
Net Debt$-25.12M
Total Equity$20.91M
Debt / Equity0.24
Valuation Ratios
P/E Ratio-2.8
P/S Ratio122.85
P/B Ratio56.89
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message